Bangladesh is going to export drugs in USA this March for the first time

For the first time, Bangladesh is going to export medicines to the USA in March this year. The President of Bangladesh Association of Pharmaceutical Industries (BAPI) Mr. Nazmul Hasan Papon said in a seminar organized by Brac University yesterday.

In a seminar titled “Challenges and opportunities for sustainable growth of the Pharmaceuticals industry in Bangladesh” held in Brac Center Mr. Papon said “When I go to England or Australia, I hear that grown-up children want to wear the Bangladesh Cricket shirt, collect Bangladesh Flag. I would like to assure you that within four years Bangladesh Pharmaceutical Industry will reach in that position also. For the first time in history, it is going to happen to export the medicines to the USA in March this year.”

The keynote speaker of this seminar was the Professor of the Finance & Economics Department of Rutgers University (USA) Mr. Hasan Mahmud. Though he praised the progress of the pharmaceutical sector, he thinks that there is a deficit of research to grow this industry. According to him, industries could be hampered unless the drug discovery. Though Bangladesh has extended the TRIPS Agreement to produce the patent drugs here up to 2033 as LDC, as the country is moving up it may not be as LDC then. That’s why we need to be prepared for this.

The Advisor of Brac Business School Mr. Rahim Talukder said there is need a for coordination between the drug manufacturers and researchers.

The teacher of the Institute of Business Administration Mr. Anwar Syed Farhat said in this seminar, now Square Pharma, Incepta Pharma & Beximco Pharma are now working only with Dhaka University for a short time.

The seminar was attended by the representatives of the country’s top pharmaceuticals. Many of them said the a shortage of skilled manpower. The Head of the Department of Pharmacy of Brac University Mrs. Eva Rahman Kabir said, there is a need to discuss what the pharmaceutical companies want from the university.

Meanwhile, the President of the Bangladesh Association of Pharmaceutical Industries (BAPI) Mr. Nazmul Hasan Papon said the course curriculum covers the subjects that are taught not suitable for global markets. But those who are working in pharmaceutical companies, are suitable for the domestic market. Once upon a time, the drug market was in the hands of foreign companies. Now the top 10 are domestic companies. The Bangladeshis are working efficiently here. They learn faster when the matters come in front.

According to the seminar, several international institutions are now becoming interested in working with Bangladesh. The drugs manufactured in Bangladesh are being marketed to Sandoz Singapore, Myanmar, and other companies. These drugs are being exported to Australia and European countries also said in the seminar.

Check Also

Novo Nordisk raises awareness about diabetes

(Saykot Murtaza): Novo Nordisk, a Danish multinational pharmaceutical company, will observe World Health Day on …

Leave a Reply

Your email address will not be published. Required fields are marked *